These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17338122)
1. [Changes in the percentage of activated lymphocytes in bronchoalveolar lavage fluid in patients with clinical improvement of sarcoidosis]. Piesiak P; Jankowska R; Passowicz-Muszyńska E Wiad Lek; 2006; 59(9-10):644-8. PubMed ID: 17338122 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor receptors (TNFRs) on T lymphocytes and soluble TNFRs in different clinical courses of sarcoidosis. Kieszko R; Krawczyk P; Chocholska S; Bojarska-Junak A; Jankowska O; Król A; Roliński J; Milanowski J Respir Med; 2007 Mar; 101(3):645-54. PubMed ID: 16889950 [TBL] [Abstract][Full Text] [Related]
3. [Measurement of T cell subsets in bronchoalveolar lavage fluid for diagnosis of pulmonary sarcoidosis]. He QY; Kitamura S; Ishii Y Zhonghua Yi Xue Za Zhi; 1994 Feb; 74(2):87-9, 126-7. PubMed ID: 8069727 [TBL] [Abstract][Full Text] [Related]
4. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Drent M; Grutters JC; Mulder PG; van Velzen-Blad H; Wouters EF; van den Bosch JM Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):31-8. PubMed ID: 9186987 [TBL] [Abstract][Full Text] [Related]
5. The clinical significance of interleukin 18 assessment in sarcoidosis patients. Kieszko R; Krawczyk P; Jankowska O; Chocholska S; Król A; Milanowski J Respir Med; 2007 Apr; 101(4):722-8. PubMed ID: 17015003 [TBL] [Abstract][Full Text] [Related]
6. Cellular components of the bronchoalveolar lavage correlate with lung function impairment and extrapulmonary involvement markers in active sarcoidosis. Chorostowska-Wynimko J; Leśniewska-Radomska D; Krychniak-Soszka A; Remiszewski P; Szopiński J; Wesołowski S; Kuś J; Skopińska-Rózewska E J Physiol Pharmacol; 2004 Sep; 55 Suppl 3():41-7. PubMed ID: 15611592 [TBL] [Abstract][Full Text] [Related]
7. T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosis. Darlington P; Haugom-Olsen H; von Sivers K; Wahlström J; Runold M; Svjatoha V; Porwit A; Eklund A; Grunewald J J Intern Med; 2012 Nov; 272(5):465-71. PubMed ID: 22469005 [TBL] [Abstract][Full Text] [Related]
8. [Correlation between bronchoalveolar lavage fluid angiotensin converting enzyme levels and T cell subsets in patients with sarcoidosis]. Li ZH; Li YL; Hou XM Zhonghua Jie He He Hu Xi Za Zhi; 1994 Aug; 17(4):235-7, 255-6. PubMed ID: 7834789 [TBL] [Abstract][Full Text] [Related]
9. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715 [TBL] [Abstract][Full Text] [Related]
10. [The relation between lymphocyte profile in BALF and the course of sarcoidosis based on short term observation]. Płodziszewska M; Chorostowska J; Polubiec-Kownacka M; Jaroń B; Lenarcik D; Marzinek M; Szopiński J; Wiatr E; Załeska J; Zych J; Skopińska-Rózewska E; Rowińska-Zakrzewska E Pneumonol Alergol Pol; 2000; 68(11-12):557-65. PubMed ID: 11320566 [TBL] [Abstract][Full Text] [Related]
11. Comparison of induced sputum and bronchoalveolar lavage fluid cell profile during the treatment of pulmonary sarcoidosis. Mroz RM; Korniluk M; Stasiak-Barmuta A; Chyczewska E J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):445-52. PubMed ID: 18204157 [TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis. Reichenberger F; Kleiber B; Baschiera B; Bubendorf L; Brutsche M; Dalquen P; Tamm M Respir Med; 2007 Sep; 101(9):2025-30. PubMed ID: 17587560 [TBL] [Abstract][Full Text] [Related]
13. [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases]. Kopiński P; Przybylski G; Jarzemska A; Sładek K; Soja J; Iwaniec T; Balicka-Slusarczyk B; Pinis G; Dyczek A; Szabłowska K; Golińska J; Jankowski M; Szczeklik J Pol Merkur Lekarski; 2007 Jul; 23(133):15-21. PubMed ID: 18051824 [TBL] [Abstract][Full Text] [Related]
14. Activated CD8+ T cells and natural killer T cells in bronchoalveolar lavage fluid in hypersensitivity pneumonitis and sarcoidosis. Tøndell A; Rø AD; Børset M; Moen T; Sue-Chu M Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):316-24. PubMed ID: 25591143 [TBL] [Abstract][Full Text] [Related]
15. [Studies of lymphocyte subpopulations of bronchoalveolar lavage fluid in HTLV-I seropositive patients with uveitis]. Mukae H; Morikawa T; Kusano S; Sawa H; Sakito O; Morikawa N; Oda H; Kadota J; Kohno S; Hara K Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Nov; 31(11):1397-404. PubMed ID: 8277609 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Heron M; Slieker WA; Zanen P; van Lochem EG; Hooijkaas H; van den Bosch JM; van Velzen-Blad H Clin Immunol; 2008 Mar; 126(3):338-44. PubMed ID: 18182176 [TBL] [Abstract][Full Text] [Related]
17. CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by single antigen inhalation. Grubek-Jaworska H; Hoser G; Droszcz P; Chazan R Med Sci Monit; 2001; 7(5):878-83. PubMed ID: 11535927 [TBL] [Abstract][Full Text] [Related]